LATHAM & WATKINS EXPANDS HEALTHCARE & LIFE SCIENCES PRACTICE WITH TWO DISTINGUISHED PARTNERS IN D.C.

Jennifer Bragg and William (Bill) McConagha bring substantial experience enhancing the firm's FDA regulatory, compliance, and enforcement offerings WASHINGTON, May 20, 2024 /PRNewswire/ -- Latham & W

PR NewswireMay 20 22:00

Latham Group Price Target Raised to $4.00/Share From $2.50 by Barclays

Latham Group Price Target Raised to $4.00/Share From $2.50 by Barclays

Dow JonesMay 14 02:02

Latham Group Is Maintained at Equal-Weight by Barclays

Latham Group Is Maintained at Equal-Weight by Barclays

Dow JonesMay 14 02:02

Barclays Maintains Equal-Weight on Latham Group, Raises Price Target to $4

Barclays analyst Matthew Bouley maintains Latham Group with a Equal-Weight and raises the price target from $2.5 to $4.

Analyst UpgradesMay 14 01:53

Latham Group Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 5.26% Barclays $2.5 → $4 Maintains Equal-Weight 03/18/2024 5.26% Stifel $3 → $4 Upgrades Hold →

BenzingaMay 14 01:50

Latham Group (SWIM) Receives a Rating Update From a Top Analyst

TipRanksMay 13 15:46